These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28447413)

  • 1. Laboratory measurement of the direct oral anticoagulants: Indications and impact on management in clinical practice.
    Wright C; Brown R; Cuker A
    Int J Lab Hematol; 2017 May; 39 Suppl 1():31-36. PubMed ID: 28447413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective study of clinical settings, indications and consequences of measurement of direct oral anticoagulant plasma levels in Northern Tasmania, Australia.
    Lim MS; Mohamed M
    Intern Med J; 2024 Jun; 54(6):932-940. PubMed ID: 38213182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an UHPLC-UV-Method for Quantification of Direct Oral Anticoagulants: Apixaban, Rivaroxaban, Dabigatran, and its Prodrug Dabigatran Etexilate in Human Serum.
    Boehr S; Haen E
    Ther Drug Monit; 2017 Feb; 39(1):66-76. PubMed ID: 27861316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Assessment of Pharmacokinetic Drug-Drug Interactions of Direct Oral Anticoagulants: Type 5-Phosphodiesterase Inhibitors Are Inhibitors of Rivaroxaban and Apixaban Efflux by P-Glycoprotein.
    Margelidon-Cozzolino V; Hodin S; Jacqueroux E; Delézay O; Bertoletti L; Delavenne X
    J Pharmacol Exp Ther; 2018 Jun; 365(3):519-525. PubMed ID: 29572341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Acting Oral Anticoagulants Following Gastrointestinal Tract Surgery.
    Hakeam HA; Alkhani M; Alyahya Z; Alawaji Z; Ofori S
    J Cardiovasc Pharmacol; 2021 Dec; 78(6):867-874. PubMed ID: 34882113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy.
    Finks SW; Trujillo TC; Dobesh PP
    Ann Pharmacother; 2016 Jun; 50(6):486-501. PubMed ID: 26917821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care.
    Gulilat M; Tang A; Gryn SE; Leong-Sit P; Skanes AC; Alfonsi JE; Dresser GK; Henderson SL; Rose RV; Lizotte DJ; Teft WA; Schwarz UI; Tirona RG; Kim RB
    Can J Cardiol; 2017 Aug; 33(8):1036-1043. PubMed ID: 28754389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.
    Gouin-Thibault I; Freyburger G; de Maistre E; Susen S; Delavenne X; Golmard JL; Gruel Y; Sié P;
    Thromb Res; 2017 Oct; 158():126-133. PubMed ID: 28892657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.
    Draper E; Parkhurst B; Carley B; Krueger K; Larson T; Griesbach S
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):475-479. PubMed ID: 28887621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban or Apixaban for Non-Valvular Atrial Fibrillation　- Efficacy and Safety of Off-Label Under-Dosing According to Plasma Concentration.
    Suwa M; Morii I; Kino M
    Circ J; 2019 Apr; 83(5):991-999. PubMed ID: 30918237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the cost-utility of direct oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in Spain].
    Monreal-Bosch M; Soulard S; Crespo C; Brand S; Kansal A
    Rev Neurol; 2017 Mar; 64(6):247-256. PubMed ID: 28272725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug Interactions.
    Pan EY; Sobieraj DM
    Conn Med; 2016 Feb; 80(2):105-11. PubMed ID: 27024982
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ
    Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
    Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
    Wu M; Gabriels J; Khan M; Shaban N; D'Amato S; Liu CF; Markowitz SM; Ip JE; Thomas G; Singh P; Lerman B; Patel A; Cheung JW
    Heart Rhythm; 2018 Apr; 15(4):496-502. PubMed ID: 29605015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study.
    Ibáñez L; Sabaté M; Vidal X; Ballarin E; Rottenkolber M; Schmiedl S; Heeke A; Huerta C; Martin Merino E; Montero D; Leon-Muñoz LM; Gasse C; Moore N; Droz C; Lassalle R; Aakjaer M; Andersen M; De Bruin ML; Groenwold R; van den Ham HA; Souverein P; Klungel O; Gardarsdottir H
    Br J Clin Pharmacol; 2019 Nov; 85(11):2524-2539. PubMed ID: 31318059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct oral anticoagulant drug level testing in clinical practice: A single institution experience.
    Martin K; Moll S
    Thromb Res; 2016 Jul; 143():40-4. PubMed ID: 27179131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System.
    Ishii M; Kaikita K; Ito M; Sueta D; Arima Y; Takashio S; Izumiya Y; Yamamoto E; Yamamuro M; Kojima S; Hokimoto S; Yamabe H; Ogawa H; Tsujita K
    Sci Rep; 2017 Aug; 7(1):7399. PubMed ID: 28785005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.